Joined November 2014
- Tweets 203
- Following 803
- Followers 779
- Likes 87
58 Photos and videos
13 Jun 2025
Check out our review article describing recent updates in LAG3 biology and therapeutics in @TrendsinPharma with @jwang133 and @Curie_Bio colleagues: authors.elsevier.com/c/1lFgx…
2
508
12 Jun 2025
Proud to have our work with @CarolynBertozzi
and Ron Levy on tumor-targeted cancer therapeutics featured in the @StanfordOTL annual report tinyurl.com/pawxhfhx; now being developed at TwoStep Therapeutics, led by lab alum Caitlyn Miller @CaitlynBioE
3
198
15 May 2025
Congrats to lab alum Bob Chen and the @OmniAbTech team on winning "Best in Show" at @PEGSboston for their innovative and impactful xPloration B cell/ Ab screening platform.
15 May 2025
🏆 Congratulations to @OmniAbTech , Inc. — winner of the Best of Show Award at #PEGSummit 2025!
Their xPloration® Partner Access Program captured attendee votes by a landslide for its innovation and impact.
Thanks to all who participated, and congrats again to the OmniAb team!
3
258
15 May 2025
Excited to see our lab's B cell screening technology, spearheaded by Cochran alum and xCella Biosciences co-founder Bob Chen, rolled out as a now commercial instrument from antibody discovery company @OmniAbTech.
13 May 2025
OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit
investors.omniab.com/investo…
3
189
CochranLab retweeted
26 Mar 2025
Congratulations to Professor Jennifer Cochran @CochranLab who was recently elected to the National Academy of Engineering @theNAEng for protein discovery and development, biotechnology entrepreneurship, and leadership in academic bioengineering!
news.stanford.edu/stories/20…
3
16
715
CochranLab retweeted
14 Mar 2024
I'm excited to share our work "Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function" that's now out in PNAS! 1/3
Link to paper: pnas.org/doi/10.1073/pnas.23…
Link to press release: news.stanford.edu/2024/03/11…
3
7
26
2,886
CochranLab retweeted
11 Jul 2023
#JI_TopRead from @CaitlynBioE @CochranLab @CarolynBertozzi @StanfordHealth | #TLR9 agonist, PIP-CpG, enhances the CD8 #Tcell response to spontaneous tumors | #ReadTheJI #immunology #AuthorChoice #FreetoRead #TumorImmunology
👉 ow.ly/FTbV50P6FNv
7
15
7,871
In the physiologically relevant MMTV-PyMT GEMM model, @CaitlynBioE @BarfiIdit @CarolynBertozzi demonstrated that systemic delivery of a tumor integrin-targeted TLR9 agonist (PIP-CpG) led to sustained elimination [...] bit.ly/3Cu9QTC
3
10
9,638
CochranLab retweeted
1 Jun 2023
Thrilled to announce that our new PIP-CpG paper is now live @J_Immunol . PIP-CpG is a tumor-targeting immunotherapy that is in preclinical development & we are hoping to advance it to the clinic in the coming years. doi.org/10.4049/jimmunol.220… .
A 🧵👇(1/13)
4
11
48
17,859
28 Apr 2023
Congrats to joint @StanfordBioE PhD student @hollander_mj, @CarolynBertozzi and team for this exciting collaborative work!
2
726
CochranLab retweeted
6 Jan 2023
Wonderful insights and leadership from @Stanford @StanfordMed @CochranLab @KarlDeisseroth @drcwestphal
#Longwoodhealthcareleaders
2
2
546
CochranLab retweeted
22 Jun 2022
Congratulations to faculty fellows @alaurenoconnell, @CyertMartha & Jennifer Cochran @CochranLab for winning the 2022 @StanfordMedOFDD Faculty Women’s Forum Awards!
Learn more: stanford.io/3zt8wQz
3
14
CochranLab retweeted
23 May 2022
Immensely enjoyed the reviewing experience and spending the day-and-a-half on @Stanford campus with this special group of people @kumarlabucb @Widya__Mulya @chubaoyolu @TejalADesai and Darelene Soloman of @Agilent. Thank you @StanfordBioE @CochranLab for the hospitality!
23 May 2022
Honored to serve on the External Review Committee for @StanfordBioE last week! Inspiring dept, brilliantly led by @CochranLab. Plus the views are pretty nice... Joined by @Widya__Mulya, @chubaoyolu, and @raviradhak, along w @TejalADesai and Darlene Solomon (not shown). 🌲
1
15
CochranLab retweeted
2 May 2022
Join #PEGS22 Plenary Keynote Jennifer Cochran, PhD, today at 4:10pm to discuss challenges and opportunities in developing non-antibody protein therapeutics. pegsummit.com/plenary-keynot…
1
8
CochranLab retweeted
3 May 2022
TLR9 (CpG) agonist was chemically conjugated to polyspecific integrin-binding peptide (PIP) that is capable to localise various types of solid tumours as explained by Caitlyn Miller from @CochranLab at @Stanford #PEGS22 @PEGSboston
3
14
3 May 2022
Excited to share this collaborative work published in Cell on an exquisite drug-regulated CAR platform. Led by Louai Labanieh, jointly advised Bioengineering PhD student in the lab of @cm35c
27 Apr 2022
Thrilled to announce that our SNIP paper is live @CellCellPress! SNIP is a high-performance drug-regulated CAR platform that is optimized for the clinic--plans for a trial are already underway @StanfordMed.
#CART #Immunotherapy #SynBio #Cancer.
sciencedirect.com/science/ar…
1/
1
14
CochranLab retweeted
8 Apr 2022
Read Jennifer Cochran's recent @CellChemBiol article: Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression @CochranLab #AACR22 hubs.li/Q017Kf5f0
2
8
19 Mar 2022
Thrilled to share our exciting collaborative work with @CarolynBertozzi, Ron Levy, @SCIDirector Steve Artandi featured on the cover of @CellChemBiol, led by the talented @CaitlynBioE and @BarfiIdit.
18 Mar 2022
Excited to see our research featured on the cover of this month’s issue of @CellChemBiol. Check out our article “Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression” at dlvr.it/SCNw48 @CarolynBertozzi
1
6
CochranLab retweeted
13 Jan 2022
Happy to share our lab's first manuscript. In work led by @JTheruvath_MD, we tested a combo of FDA approved anti-GD2 with blockade of CD47, a macrophage checkpoint. Blocking CD47 unleashes patients' macrophages to phagocytose or 'eat' cancer cells. Combo was highly effective! 1/
13 Jan 2022
📢 New in @NatureMedicine! Great work led by @Majzner_Lab @JTheruvath_MD shows that the combo of anti-GD2 CD47 blockade ⬆️ anti-tumor activity in 🐭 models of #neuroblastoma, #osteosarcoma & #lungcancer by modulating #macrophage activity #immunotherapy nature.com/articles/s41591-0…
8
32
117
12 Jul 2021
On July 19, learn about how next-generation engineered proteins target stromal factors can remodel an immunosuppressive tumor microenvironment at the #PEGSymposium
2